Lilian Alcaraz

Corporate Officer/Principal at Pulmagen Therapeutics (Synergy) Ltd.

Finance

Commercial Services

Consumer Services

Profile

Lilian Alcaraz is currently working as the Director-Chemistry at Pulmagen Therapeutics (Synergy) Ltd.
and as the Vice President & Early Innovation Partnering EMEA at Johnson & Johnson Innovation - JJDC, Inc. She holds a doctorate degree from Universite Louis Pasteur Strasbourg I, which she obtained in 1995.

Lilian Alcaraz active positions

Companies	Position	Start
Pulmagen Therapeutics (Synergy) Ltd. Pulmagen Therapeutics (Synergy) Ltd. Miscellaneous Commercial ServicesCommercial Services Pulmagen Therapeutics (Synergy) Ltd. develops therapeutics for respiratory diseases. It engages in developing various internal proprietary programs in chronic obstructive pulmonary disease, asthma, and cystic fibrosis. The company was founded in August 2000 and is headquartered in Stevenage, the United Kingdom.	Corporate Officer/Principal	-
Johnson & Johnson Innovation - JJDC, Inc. Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey.	Private Equity Investor	2021-02-28

All active positions of Lilian Alcaraz

Training of Lilian Alcaraz

Universite Louis Pasteur Strasbourg I

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Lilian Alcaraz's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Johnson & Johnson Innovation - JJDC, Inc. Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey.	Finance
Pulmagen Therapeutics (Synergy) Ltd. Pulmagen Therapeutics (Synergy) Ltd. Miscellaneous Commercial ServicesCommercial Services Pulmagen Therapeutics (Synergy) Ltd. develops therapeutics for respiratory diseases. It engages in developing various internal proprietary programs in chronic obstructive pulmonary disease, asthma, and cystic fibrosis. The company was founded in August 2000 and is headquartered in Stevenage, the United Kingdom.	Commercial Services